Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62017TN0776

Case T-776/17: Action brought on 28 November 2017 — Medora Therapeutics v EUIPO — Biohealth Italia (LITHOREN)

OJ C 63, 19.2.2018, pp. 13–14 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

19.2.2018   

EN

Official Journal of the European Union

C 63/13


Action brought on 28 November 2017 — Medora Therapeutics v EUIPO — Biohealth Italia (LITHOREN)

(Case T-776/17)

(2018/C 063/18)

Language in which the application was lodged: English

Parties

Applicant: Medora Therapeutics LTD (Halandri, Greece) (represented by: S. Santos Rodríguez, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Biohealth Italia Srl (Rivoli, Italy)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘LITHOREN’ — EU trade mark No 12 744 901

Procedure before EUIPO: Proceedings for a declaration of invalidity

Contested decision: Decision of the Second Board of Appeal of EUIPO of 14 September 2017 in Case R 178/2017-2

Form of order sought

The applicant claims that the Court should:

annul the contested decision;

order EUIPO to pay the costs, including those incurred in the proceedings before EUIPO.

Pleas in law

Infringement of Article 53(1)(a) of Regulation No 207/2009;

Infringement of Article 8(1)(b) of Regulation No 207/2009.


Top